Secondary Logo

Journal Logo

Editorial introductions

Editorial introductions

Current Opinion in Lipidology: April 2008 - Volume 19 - Issue 2 - p vii-viii
doi: 10.1097/MOL.0b013e3282fbf32b
  • Free

Current Opinion in Lipidology was launched in 1990. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of lipidology is divided into six sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.

Section Editors

E Shyong Tai

Figure 1
Figure 1

E Shyong Tai, MD, trained in medicine at the University of Dundee, UK, before returning to Singapore where he trained first in internal medicine, and then as an endocrinologist at the Singapore General Hospital. He is a Member of the Royal College of Physicians in the UK, and a Fellow of the Academy of Medicine in Singapore (Endocrinology).

As part of his training as an endocrinologist, Dr Tai completed an 18-month research fellowship at the USDA Human Nutrition Research Center on Aging at Tufts University, USA, where he worked on the interactions between genetic and environmental factors as pertaining to hyperlipidemia and atherosclerotic risk. Dr Tai returned to Singapore again in 2002, and is currently employed as a Clinician Scientist at the Singapore Health Service, one of the two major providers of public healthcare in Singapore. In 2005, he was the recipient of the Clinician Scientists Investigator Award, a national award from the Biomedical Research and the National Medical Research Councils in Singapore.

Dr Tai's major research interests revolve around diabetes mellitus, dyslipidemia, and their relations with atherosclerotic disease. He is involved in several large studies examining the role of genetic and environmental factors and their interactions in the pathogenesis of these chronic disorders. He is also involved in more traditional epidemiology, and has been instrumental in defining the burden of disease associated with diabetes and its associated traits in the Asia–Pacific region. Finally, he is involved in several clinical trials that examine the effects of various treatments on the modulation of cardiovascular risk factors.

Dr Tai has published over 50 articles in peer-reviewed journals, including several reviews. He speaks regularly at international and regional congresses on the diagnosis, treatment and pathogenesis of diabetes, dyslipidemia, and other metabolic traits. Dr Tai serves on the Editorial Board of Atherosclerosis, and is a frequent reviewer for several other journals for manuscripts related to dyslipidemia and atherosclerosis. Furthermore, over the past several years, Dr Tai has served on committees that write the clinical practice guidelines for the Ministry of Health in the areas lipids, diabetes mellitus and obesity.

Jose M. Ordovas

Figure 2
Figure 2

Jose M. Ordovas, PhD, is Professor of Nutrition and a Senior Scientist (USDA-HNRC) at Tufts University in Boston, USA, where he also is a Director of the Nutrition and Genomics Laboratory, HNRCA.

Dr Ordovas was educated in Spain at the University of Zaragoza, where he completed his undergraduate work in chemistry, his graduate work in biochemistry, and received his doctorate in biochemistry. While earning his doctorate, Dr Ordovas served as a teaching assistant at the University's Department of Biochemistry and Nutrition. He then joined Massachusetts Institute of Technology in Boston, as a research associate in the Department of Nutrition and Food Science. He continued as a research associate with Harvard Medical School's Department of Cardiology, Children's Hospital, and then at Tufts University, Lipid Metabolism Laboratory, USDA Human Nutrition Research Center on Aging, and in 2000 became the Director of the Nutrition and Genomics Laboratory.

Dr Ordovas' major research interests focus on the genetic factors that predispose to cardiovascular disease, their interaction with the environment, and behavioral factors with special emphasis on diet. He has participated in the Framingham Heart Study for over 20 years, and is carrying out multiple cross-cultural studies to determine cardiovascular risk in different populations around the world, with special interest in the Asia–Pacific and the Mediterranean regions.

Dr Ordovas has published over 450 scientific articles in peer-review journals, and written numerous reviews and books on topics surrounding diet and coronary heart disease, diet and genetics, and the pathophysiology of arteriosclerosis. Dr Ordovas frequently participates as invited speaker in international congresses, courses and symposiums around the world. These lectures have focused primarily on dietary prevention and treatment of cardiovascular disease, Mediterranean diet, cultural transition in the Asia–Pacific region, the interaction between genetics and the environment as a determinant of individual health risk, and the genetics of cardiovascular disease. Dr Ordovas serves on several editorial boards, is a frequent reviewer of many leading journals, and is an active member of the NIH and AHA peer-review committees. Throughout his career, Dr Ordovas has contributed his expertise to various global organizations, and has received many honors for his scientific achievements, including the USDA Secretary's Award and other awards from the American Society for Nutrition and the American Association for Clinical Chemistry. He serves on the scientific advisory boards of several biotechnology and nutrigenomic companies. He is also a member of the Institute of Medicine's Food and Nutrition Board.

© 2008 Lippincott Williams & Wilkins, Inc.